Bonimen
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80086220
- Status
- Active licence
- Licence date
- 14 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 3.34 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Prunus africana Source : Écorce (tige) Potency : 25 % Phytosterols | Not specified | Not calculated |
| Zinc Source : Oxyde de zinc | 5 milligramme | 10,000 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle Potency : 10 UI | 6.7 mcg AT | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.67 milligramme | 3,340 µg |
| Cuivre Source : Gluconate de cuivre (II) | 100 microgrammes | Not calculated |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 70 microgrammes | Not calculated |
| Serenoa repens Source : Fruit Potency : 45 % Fatty acids | 200 milligramme | Not calculated |
| Cucurbita pepo Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
| Prunus africana Source : Écorce (tige) Potency : 13 % beta-Sitosterol | 50 milligramme | Not calculated |
| Taraxacum officinale Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 milligramme | 30 milligramme | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 milligramme | 50 milligramme | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 milligramme | 25 milligramme | Not calculated |
| Vaccinium macrocarpon Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 milligramme | 25 milligramme | Not calculated |
| Agathosma crenulata Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 milligramme | 25 milligramme | Not calculated |
| Lycopène tout trans Source : Lycopène | 1.5 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Silice pyrogénée, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Source of/An antioxidant for the maintenance of good health. Helps reduce the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with benign prostatic hyperplasia. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to maintain immune function. Helps to maintain the body's ability to metabolize nutrients. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. If you have liver or gall bladder diseases, and/or intestinal obstruction, consult a health care practitioner prior to use. If you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a history of kidney stones. Consult a health care practitioner prior to use if you are taking blood thinners. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
Source
Official Health Canada record, licence 80086220
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.